Filing Details
- Accession Number:
- 0001474506-21-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-12 16:56:40
- Reporting Period:
- 2021-04-08
- Accepted Time:
- 2021-04-12 16:56:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 200028718 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1564990 | Philip Ashman | 6120 Windward Parkway, Suite 290 Alpharetta GA 30005 | Chief Operating Officer & Svp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-08 | 45 | $9.62 | 19,379 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Dr. Ashman's sale of ALIM common stock was an involuntary sale to maintain a minimum cash balance by the online platform service provider used by his financial advisor. The sale, which was made without Dr. Ashman's knowledge or permission, was matchable under Section 16(b) of the Securities Exchange Act of 1934. Dr. Ashman has agreed to pay to ALIM, upon settlement of the sale, $225.39, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
Billionaire Hedge Funds
